Herein, by using online databases, we explored the expression changes, prognosis value, interacting genes, especially the cancer stem cell biomarkers, and the altered signal pathways of MYC during breast cancer tumorigenesis, hoping to shed light on the new biomarkers and therapeutic targets for breast cancer. This evidence concerns the gene MYC and breast cancer.